Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Glucocerebrosidase is present in α-synuclein inclusions in Lewy body disorders.

Acta neuropathologica - 1 Nov 2010

Goker-Alpan Ozlem, Stubblefield Barbara K, Giasson Benoit I, Sidransky Ellen

Abstract excerpt

Mutations in the gene encoding the lysosomal enzyme glucocerebrosidase, known to cause Gaucher disease (GD), are a risk factor for the development of Parkinson disease (PD) and related disorders. This association is based on the concurrence of parkinsonism and GD, the identification of glucocereb...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to alpha-Synuclein
Share to Gaucher Disease
Share to Glucosylceramidase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lewy Bodies

Share to Lewy Body Disease

Share to Microscopy, Confocal

Share to Neurites

Share to Ubiquitination

Source

Open in PubMed Open full text

Identifiers

PMID: 20838799
DOI: 10.1007/s00401-010-0741-7
PMCID: PMC3352317

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20838799-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Glucocerebrosidase is present in α-synuclein inclusions in Lewy body disorders.PMID 20838799Read ↗

Glucocerebrosidase mutations are an important risk factor for Lewy body disorders.Semantic proximity Read ↗

Glucocerebrosidase mutations and synucleinopathies: Toward a model of precision medicineSemantic proximity Read ↗

Glucocerebrosidase and its relevance to Parkinson diseaseSemantic proximity Read ↗

Glucocerebrosidase, a new player changing the old rules in Lewy body diseases.Semantic proximity Read ↗

Glucocerebrosidase is shaking up the synucleinopathies.Semantic proximity Read ↗

Glucocerebrosidase in Parkinson's disease: Insights into pathogenesis and prospects for treatmentSemantic proximity Read ↗

The role of glucocerebrosidase mutations in Parkinson disease and Lewy body disorders.Semantic proximity Read ↗

Gaucher-related synucleinopathies: the examination of sporadic neurodegeneration from a rare (disease) angle.Semantic proximity Read ↗

The association between ß-glucocerebrosidase mutations and parkinsonism.Semantic proximity Read ↗

Enhancing the Activity of Glucocerebrosidase as a Treatment for Parkinson Disease.Semantic proximity Read ↗

Glucocerebrosidase mutations: A paradigm for neurodegeneration pathways.Semantic proximity Read ↗

Glucocerebrosidase as a therapeutic target for Parkinson's disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.